New cytotoxic agents and schedules for advanced breast cancer

被引：21

作者：

Burstein, HJ

Bunnell, CA

Winer, EP

机构：

[1] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA

[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 04期

关键词：

D O I：

10.1053/sonc.2001.26146

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：344 / 358

页数：15

相关论文

共 170 条

[31] DOCETAXEL IS A MAJOR CYTOTOXIC DRUG FOR THE TREATMENT OF ADVANCED BREAST-CANCER - A PHASE-II TRIAL OF THE CLINICAL SCREENING COOPERATIVE GROUP OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER [J].

CHEVALLIER, B ;

FUMOLEAU, P ;

KERBRAT, P ;

DIERAS, V ;

ROCHE, H ;

KRAKOWSKI, I ;

AZLI, N ;

BAYSSAS, M ;

LENTZ, MA ;

VANGLABBEKE, M .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (02) :314-322

[32]

Chu L, 1996, J Infus Chemother, V6, P211

[33]

CLIMENT MA, 1999, P AN M AM SOC CLIN, V18, P119

[34] Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease [J].

Cobleigh, MA ;

Vogel, CL ;

Tripathy, D ;

Robert, NJ ;

Scholl, S ;

Fehrenbacher, L ;

Wolter, JM ;

Paton, V ;

Shak, S ;

Lieberman, G ;

Slamon, DJ .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2639-2648

[35] DOCETAXEL [J].

CORTES, JE ;

PAZDUR, R .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) :2643-2655

[36] Safety and efficacy of using a single agent or a phase II agent before instituting standard combination chemotherapy in previously untreated metastatic breast cancer patients: Report of a randomized study - Cancer and leukemia group B 8642 [J].

Costanza, ME ;

Weiss, RB ;

Henderson, IC ;

Norton, L ;

Berry, DA ;

Cirrincione, C ;

Winer, E ;

Wood, WC ;

Frei, E ;

McIntyre, OR ;

Schilsky, RL .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1397-1406

[37]

CRUMP M, 2001, P AN M AM SOC CLIN, V20, pA21

[38]

Cunningham D, 1996, ANN ONCOL, V7, P179

[39]

DANIELS M, 1993, JPN J CLIN ONCOL, V23, P363

[40] A multicentre phase II study of docetaxel 75 mg m(-2) as first-line chemotherapy for patients with advanced breast cancer: Report of the clinical screening group of the EORTC [J].

Dieras, V ;

Chevallier, B ;

Kerbrat, P ;

Krakowski, I ;

Roche, H ;

Misset, JL ;

Lentz, MA ;

Azli, N ;

Murawsky, M ;

Riva, A ;

Pouillart, P ;

Fumoleau, P .

BRITISH JOURNAL OF CANCER, 1996, 74 (04) :650-656

← 1 2 3 4 5 6 7 8 9 10 →